What solvent should I use to reconstitute Master Pharma IGF-1 DES 1mg vial?

Bacteriostatic water (0.9 % benzyl alcohol) is the preferred solvent for multi-dose use, extending the reconstituted solution's refrigerated shelf life to approximately 28 days. Sterile water for injection is an alternative only if the entire vial will be consumed in a single session. Always direct solvent down the vial wall slowly — never force it onto the peptide cake — to avoid foaming and peptide degradation.

How long does reconstituted IGF-1 DES remain stable in the refrigerator?

When reconstituted with bacteriostatic water and stored at 2–8 °C in a light-protected environment, IGF-1 DES solution is considered stable for up to 28 days. Using sterile water without a preservative cuts stability to 24–48 hours. Freezing the reconstituted vial is not recommended, as repeated freeze-thaw cycles break peptide bonds and reduce effective concentration.

What needle gauge and injection angle are recommended for subcutaneous IGF-1 DES?

A 29–31 gauge insulin syringe with a 6–8 mm needle is standard for subcutaneous peptide delivery. Insert at a 45° angle into pinched skin at a rotated site — abdomen, flank, or outer thigh — to deposit the solution into the subcutaneous adipose layer rather than the muscle or dermis. Consistent site rotation prevents cumulative localised irritation.

How do I calculate the correct volume to draw from a 1mg IGF-1 DES vial?

Add exactly 1 mL of bacteriostatic water to the 1 mg vial to yield 1000 mcg/mL (1 mcg per microlitre). For a 50 mcg dose, draw 0.05 mL on an insulin syringe. Master Pharma's batch HPLC certificate confirms the declared 1 mg peptide mass, so your concentration calculation rests on independently verified starting material rather than an estimate.

Why does Master Pharma carry out LAL endotoxin testing on IGF-1 DES vials?

The Limulus Amebocyte Lysate (LAL) test detects bacterial endotoxins that survive standard sterilisation and cause injection-site inflammation or systemic pyrogenic reactions. Master Pharma applies LAL testing to every batch of lyophilised peptide vials, including IGF-1 DES, and the results are included in lot-specific documentation. This directly reduces the risk that post-injection redness or swelling stems from microbial contamination rather than the peptide itself. (2) angle_used

Batch Tested

Master Pharma

IGF-1 DES 1mg/vial 1 Vial by Master Pharma

Name: IGF-1 DES
Brand: Master Pharma
SKU: PEPT-IGFD-MAS-003
Price: 36.00 EUR
Availability: InStock

Master Pharma IGF-1 DES is a lyophilised, single-ingredient research peptide supplied as 1 mg per vial, engineered for subcutaneous administration following correct reconstitution with bacteriostatic water. Proper handling — precise solvent volume, refrigerated storage at 2–8 °C, and aseptic injection technique — determines whether the peptide reaches target tissue at full potency. Each vial lot is covered by batch-specific HPLC purity and LAL endotoxin documentation, verified through independent analytical testing before release.

€36.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Lyophilised format preserves peptide bond integrity during transit and storage compared to pre-dissolved solutions
Single-ingredient vial eliminates cross-contamination variables for precise dosing accuracy
Batch-specific HPLC purity data gives a verified concentration reference before reconstitution
LAL endotoxin certification on every lot reduces injection-site inflammatory risk
1 mg per vial supports flexible dosing increments using standard insulin syringes
Compatible with bacteriostatic water for extended 28-day post-reconstitution usability

Phase	Dosage / Volume	Note
Initial reconstitution	Add 1 mL bacteriostatic water to 1 mg vial → 1000 mcg/mL	Direct solvent down vial wall; swirl gently — do not shake
Research dose — low	20–50 mcg per injection (0.02–0.05 mL)	Subcutaneous; assess individual tolerance first
Research dose — moderate	50–100 mcg per injection (0.05–0.10 mL)	Rotate injection site each administration
Frequency	1–2 × daily	Short half-life (~20–30 min) necessitates timely use after drawing
Cycle length	4–6 weeks typical	Refrigerate vial between doses; discard after 28 days post-reconstitution

Key takeaways

Reconstitute with bacteriostatic water for multi-dose refrigerated stability up to 28 days.
Store unreconstituted vials at 2–8 °C, protected from light, for up to 24 months.
Rotate subcutaneous injection sites every dose to prevent localised tissue irritation.
Verify your dose calculation against the batch HPLC certificate for confirmed starting mass.
Review LAL endotoxin results per lot before injecting to confirm microbiological safety.

What IGF-1 DES Is and Why Correct Handling Defines Its Effectiveness

IGF-1 DES (des[1-3]IGF-1) is a truncated, naturally occurring variant of Insulin-like Growth Factor-1, lacking the first three N-terminal amino acids, which substantially lowers its binding affinity for IGF-binding proteins and intensifies its direct interaction with the IGF-1 receptor at tissue level. Master Pharma supplies it as a lyophilised powder — a freeze-dried cake that requires accurate reconstitution before any subcutaneous dose is drawn. Compared to pre-dissolved peptide solutions, the lyophilised format confers superior shelf-life stability, provided storage and reconstitution protocols are followed precisely.

Reconstitution: Solvent Choice and Volume Calculation

Bacteriostatic water (0.9 % benzyl alcohol) is the recommended reconstitution solvent for IGF-1 DES vials intended for multi-dose use; sterile water for injection is acceptable for single-dose applications only. To achieve a working concentration of 100 mcg per 0.1 mL, add 1 mL of bacteriostatic water to the 1 mg vial — directing the solvent slowly down the inner vial wall rather than jetting it directly onto the peptide cake prevents foaming and preserves structural integrity. Master Pharma's lot-specific HPLC data confirms the declared 1 mg starting mass, giving users a verified reference point for their volume calculations.

Cold-Chain Storage and Post-Reconstitution Shelf Life

Unreconstituted vials must be stored at 2–8 °C, away from light; lyophilised IGF-1 DES retains potency for up to 24 months under these refrigerated conditions, per standard industry stability benchmarks. Once reconstituted, the peptide solution should remain refrigerated and is considered stable for up to 28 days, provided bacteriostatic water was used as the diluent — a timeline that shortens to 24–48 hours when sterile water alone is used. Freezing a reconstituted solution degrades peptide bonds and is not recommended.

Subcutaneous Injection Technique

Subcutaneous administration delivers IGF-1 DES into the adipose layer immediately beneath the skin, typically using a 29–31 gauge insulin syringe with a 6–8 mm needle. The injection site — commonly the abdomen, outer thigh, or flank — should be rotated with each dose to minimise localised tissue irritation. After drawing the calculated volume, expel air bubbles, pinch the skin lightly, insert the needle at a 45° angle, aspirate briefly to confirm no vessel entry, then depress the plunger steadily. LAL endotoxin testing carried out on every Master Pharma batch reduces the risk of injection-site inflammation attributable to microbial contamination rather than the peptide itself.

Usage

Gather supplies: Master Pharma IGF-1 DES 1mg vial, bacteriostatic water, 29–31 gauge insulin syringes, alcohol swabs, and a clean flat surface.
Wipe the vial septum with an alcohol swab and allow it to dry for 10 seconds before inserting any needle.
Draw 1 mL of bacteriostatic water into a syringe and inject it slowly down the inner wall of the vial — never directly onto the peptide cake.
Swirl the vial gently in a circular motion until the lyophilised cake dissolves fully into a clear solution; do not shake or vortex.
Using a fresh insulin syringe, draw the calculated dose volume, expel any air bubbles, pinch a clean subcutaneous site (abdomen, flank, or outer thigh), insert the needle at 45°, aspirate briefly, then depress the plunger steadily.
After injection, recap and dispose of the used syringe safely; recap the vial, label it with the reconstitution date, and return it to the refrigerator at 2–8 °C immediately.

Warnings

Contraindications: IGF-1 DES is not suitable for individuals with active or suspected malignancy, as IGF-1 receptor activation may promote tumour proliferation. Contraindicated in pregnancy, lactation, and in persons under 18 years of age. Those with a history of diabetic retinopathy or severe hypoglycaemia episodes should avoid use.

Side Effects: Reported effects include transient hypoglycaemia (administer alongside a carbohydrate source), injection-site erythema, and peripheral oedema. Jaw or hand tingling has been noted at higher doses. Symptoms typically resolve upon dose reduction or cessation.

Monitoring: Monitor fasting glucose and insulin sensitivity at baseline and at two-week intervals during use. Periodic IGF-1 serum assays (reference range 100–300 ng/mL for adults) provide indirect guidance on systemic exposure. Inspect each vial for particulates or discolouration before drawing a dose — discard if either is present.

PCT: IGF-1 DES does not suppress the hypothalamic-pituitary-gonadal axis directly; formal post-cycle therapy is not required for isolated peptide use. When co-administered with anabolic steroids or growth hormone secretagogues, PCT should be structured around those compounds rather than IGF-1 DES specifically.

Frequently asked questions

What solvent should I use to reconstitute Master Pharma IGF-1 DES 1mg vial?: Bacteriostatic water (0.9 % benzyl alcohol) is the preferred solvent for multi-dose use, extending the reconstituted solution's refrigerated shelf life to approximately 28 days. Sterile water for injection is an alternative only if the entire vial will be consumed in a single session. Always direct solvent down the vial wall slowly — never force it onto the peptide cake — to avoid foaming and peptide degradation.
How long does reconstituted IGF-1 DES remain stable in the refrigerator?: When reconstituted with bacteriostatic water and stored at 2–8 °C in a light-protected environment, IGF-1 DES solution is considered stable for up to 28 days. Using sterile water without a preservative cuts stability to 24–48 hours. Freezing the reconstituted vial is not recommended, as repeated freeze-thaw cycles break peptide bonds and reduce effective concentration.
What needle gauge and injection angle are recommended for subcutaneous IGF-1 DES?: A 29–31 gauge insulin syringe with a 6–8 mm needle is standard for subcutaneous peptide delivery. Insert at a 45° angle into pinched skin at a rotated site — abdomen, flank, or outer thigh — to deposit the solution into the subcutaneous adipose layer rather than the muscle or dermis. Consistent site rotation prevents cumulative localised irritation.
How do I calculate the correct volume to draw from a 1mg IGF-1 DES vial?: Add exactly 1 mL of bacteriostatic water to the 1 mg vial to yield 1000 mcg/mL (1 mcg per microlitre). For a 50 mcg dose, draw 0.05 mL on an insulin syringe. Master Pharma's batch HPLC certificate confirms the declared 1 mg peptide mass, so your concentration calculation rests on independently verified starting material rather than an estimate.
Why does Master Pharma carry out LAL endotoxin testing on IGF-1 DES vials?: The Limulus Amebocyte Lysate (LAL) test detects bacterial endotoxins that survive standard sterilisation and cause injection-site inflammation or systemic pyrogenic reactions. Master Pharma applies LAL testing to every batch of lyophilised peptide vials, including IGF-1 DES, and the results are included in lot-specific documentation. This directly reduces the risk that post-injection redness or swelling stems from microbial contamination rather than the peptide itself. (2) angle_used

Manufacturer

Microbiological purity and endotoxin control sit at the centre of Master Pharma's lyophilised peptide release framework — not as supplementary checks, but as primary gate-keeping criteria without which no IGF-1 DES vial lot proceeds to packaging. The endotoxin burden of every batch is quantified via the Limulus Amebocyte Lysate (LAL) method, a gold-standard compendial technique specified in both USP <85> and EP 2.6.14, with acceptance limits set below 10 EU/mg for parenteral peptide preparations. Bioburden enumeration is conducted in parallel under ISO-aligned microbiology protocols, assessing total aerobic microbial count and the absence of specified pathogens — Pseudomonas aeruginosa, Staphylococcus aureus, and Enterobacteriaceae — before any release decision is taken. For IGF-1 DES, where subcutaneous injection places the peptide in direct contact with cutaneous immune surveillance, an endotoxin exceedance would manifest clinically as injection-site inflammation indistinguishable from peptide-induced irritation; Master Pharma's documented endotoxin data therefore serves a diagnostic function for the end user as much as a manufacturing compliance function. Lot-specific LAL certificates are made available alongside HPLC purity records, enabling cross-referencing of both chemical identity and microbiological status within a single batch release package.

Product details

Brand	Master Pharma
Active ingredient	igf-1 des
Also known as	DES-IGF, Des (1-3) IGF, Bio-Peptide IGF-1 DES, IGF-1 DES, Master Pharma DES-IGF
Strength	1 mg
Form	Vial
Pack size	1 piece
Item number	PEPT-IGFD-MAS-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Lab Tested

Des IGF 1mg/vial 1 Vial by Bio-Peptide

Bio-Peptide Des (1-3) IGF-1 is a truncated analogue of Insulin-Like Growth Factor-1, lyophilized at 1 mg per vial, engineered to bypass IGFBP binding proteins and deliver concentrated receptor activation directly at the injected muscle site. Absent the three N-terminal amino acids found in full-length IGF-1, this variant binds the IGF-1 receptor with approximately 10-fold greater affinity in vitro, generating intense, localized anabolic signalling that makes it the preferred tool for compartmentalized hypertrophy protocols. Each vial is independently verified through HPLC sequence confirmation and LAL endotoxin screening prior to release, ensuring batch-traceable purity and injection safety.

€36.00

HPLC Verified

IGF-1 DES 1mg/vial 1 Vial by Knoll Pharmaceuticals

Knoll Pharmaceuticals IGF-1 DES 1 mg/vial is a lyophilised truncated insulin-like growth factor peptide engineered for superior local receptor affinity, positioned here as a long-acting IGF-1 analog that drives muscle cell hyperplasia and optimises nutrient partitioning toward contractile tissue. Each single-use vial delivers a precisely measured 1 mg dose whose HPLC-confirmed purity supports reproducible anabolic signalling across lean-mass accumulation protocols. Quality assurance is independently enforced at two sequential release stages — chromatographic identity verification and LAL endotoxin testing — before any unit leaves the Knoll facility.

€30.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00